Evidence map›Paper›PMID 42941312›Full record

ArticleJournal of clinical medicine2026

Real-World Effectiveness, Documented Adverse Events, and Treatment Adherence of Semaglutide and Liraglutide in Omani Patients: A Retrospective Observational Study.

Najwa Al-Himali, Hanan Al-Habsi, Ahmed Al Mushrafi, Amal Al Shidi, Ayat Abbas, Amjaad Al Kindi, Hamza Syed, Iman Mohammadi, Amna Al Subhi, Maisa Hamed Al Kiyumi

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Najwa Al-HimaliDepartment of Pharmacy, Sultan Qaboos University Hospital, University Medical City, Muscat 123, Oman.ORCID 0000-0002-1576-6805
Hanan Al-HabsiDepartment of Pharmacy, Sultan Qaboos University Hospital, University Medical City, Muscat 123, Oman.ORCID 0009-0008-5007-1305
Ahmed Al MushrafiCollege of Medicine and Health Sciences, Sultan Qaboos University, Muscat 123, Oman.
Amal Al ShidiDepartment of Primary Health Care, Ministry of Health, Muscat 100, Oman.
Ayat AbbasDepartment of Primary Health Care, Ministry of Health, Muscat 100, Oman.
Amjaad Al KindiCollege of Medicine and Health Sciences, Sultan Qaboos University, Muscat 123, Oman.
Hamza SyedCollege of Medicine and Health Sciences, Sultan Qaboos University, Muscat 123, Oman.ORCID 0009-0003-1903-4606
Iman MohammadiDepartment of Primary Health Care, Ministry of Health, Muscat 100, Oman.
Amna Al SubhiCollege of Medicine and Health Sciences, Sultan Qaboos University, Muscat 123, Oman.
Maisa Hamed Al KiyumiDepartment of Family Medicine and Public Health, Sultan Qaboos University Hospital, University Medical City, Sultan Qaboos University, Muscat 123, Oman.ORCID 0000-0001-7500-4995

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

glucagon-like peptide-1 receptor agonistliraglutideobesityoverlap weightingpropensity scoreretrospective cohort studysemaglutidetreatment adherencetreatment persistencetype 2 diabetes mellitus

Identifiers

PMID42941312
PMCPMC13705067

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.